Lori K. Gavrin

643 total citations
9 papers, 386 citations indexed

About

Lori K. Gavrin is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Lori K. Gavrin has authored 9 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Lori K. Gavrin's work include Protein Kinase Regulation and GTPase Signaling (3 papers), Synthesis and biological activity (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Lori K. Gavrin is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (3 papers), Synthesis and biological activity (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Lori K. Gavrin collaborates with scholars based in United States, Australia and Canada. Lori K. Gavrin's co-authors include Eddine Saiah, R. Aldrin Denny, Kristin Janz, J. Perry Hall, Neelu Kaila, Yonghan Hu, Jean‐Baptiste Telliez, Huan‐Qiu Li, Neal Green and Sang Hsu and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Lori K. Gavrin

9 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori K. Gavrin United States 8 218 126 68 51 39 9 386
Henrik Moebitz Switzerland 5 325 1.5× 105 0.8× 119 1.8× 58 1.1× 28 0.7× 8 441
Amy M. Delaney United States 7 292 1.3× 83 0.7× 90 1.3× 33 0.6× 26 0.7× 8 441
Brian L. Batley United States 11 311 1.4× 150 1.2× 87 1.3× 32 0.6× 41 1.1× 18 450
Ming Guo China 8 353 1.6× 132 1.0× 134 2.0× 28 0.5× 44 1.1× 14 540
James R. Porter United States 8 350 1.6× 60 0.5× 59 0.9× 59 1.2× 28 0.7× 12 483
Annie Olivier France 10 262 1.2× 160 1.3× 153 2.3× 41 0.8× 29 0.7× 12 492
Junping Pei China 10 316 1.4× 112 0.9× 117 1.7× 26 0.5× 28 0.7× 24 523
Injae Shin South Korea 12 258 1.2× 92 0.7× 55 0.8× 24 0.5× 32 0.8× 24 418
Nicolas Warin United Kingdom 4 222 1.0× 111 0.9× 115 1.7× 27 0.5× 24 0.6× 7 394
André J. Niestroj Germany 8 188 0.9× 81 0.6× 121 1.8× 22 0.4× 43 1.1× 11 377

Countries citing papers authored by Lori K. Gavrin

Since Specialization
Citations

This map shows the geographic impact of Lori K. Gavrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori K. Gavrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori K. Gavrin more than expected).

Fields of papers citing papers by Lori K. Gavrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori K. Gavrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori K. Gavrin. The network helps show where Lori K. Gavrin may publish in the future.

Co-authorship network of co-authors of Lori K. Gavrin

This figure shows the co-authorship network connecting the top 25 collaborators of Lori K. Gavrin. A scholar is included among the top collaborators of Lori K. Gavrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori K. Gavrin. Lori K. Gavrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Denny, R. Aldrin, Lori K. Gavrin, & Eddine Saiah. (2013). Recent developments in targeting protein misfolding diseases. Bioorganic & Medicinal Chemistry Letters. 23(7). 1935–1944. 35 indexed citations
2.
Gavrin, Lori K. & Eddine Saiah. (2012). Approaches to discover non-ATP site kinase inhibitors. MedChemComm. 4(1). 41–51. 132 indexed citations
3.
Gavrin, Lori K., R. Aldrin Denny, & Eddine Saiah. (2012). Small Molecules That Target Protein Misfolding. Journal of Medicinal Chemistry. 55(24). 10823–10843. 44 indexed citations
4.
Gavrin, Lori K., Paige E. Mahaney, Lisa Nogle, et al.. (2010). Discovery of WAY-260022, a Potent and Selective Inhibitor of the Norepinephrine Transporter. ACS Medicinal Chemistry Letters. 1(3). 91–95. 2 indexed citations
5.
Moy, Franklin J., Arthur Lee, Lori K. Gavrin, et al.. (2009). Novel Synthesis and Structural Characterization of a High-Affinity Paramagnetic Kinase Probe for the Identification of Non-ATP Site Binders by Nuclear Magnetic Resonance. Journal of Medicinal Chemistry. 53(3). 1238–1249. 20 indexed citations
6.
Kaila, Neelu, Neal Green, Huan‐Qiu Li, et al.. (2007). Identification of a novel class of selective Tpl2 kinase inhibitors: 4-Alkylamino-[1,7]naphthyridine-3-carbonitriles. Bioorganic & Medicinal Chemistry. 15(19). 6425–6442. 23 indexed citations
7.
Hu, Yonghan, Neal Green, Lori K. Gavrin, et al.. (2006). Inhibition of Tpl2 kinase and TNFα production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis. Bioorganic & Medicinal Chemistry Letters. 16(23). 6067–6072. 54 indexed citations
8.
Gavrin, Lori K., et al.. (2006). Synthesis of Pyrazolo[1,5-α]pyrimidinone Regioisomers. The Journal of Organic Chemistry. 72(3). 1043–1046. 35 indexed citations
9.
Gavrin, Lori K., Neal Green, Yonghan Hu, et al.. (2005). Inhibition of Tpl2 kinase and TNF-α production with 1,7-naphthyridine-3-carbonitriles: Synthesis and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 15(23). 5288–5292. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026